Paeds Vivas · allergy-and-immunology
Immune dysregulation, lymphoproliferation and autoinflammatory disease — viva
Branching structured oral on the three-mechanism framework, the HLH/MAS threat gate, and pathway-targeted therapy for monogenic immune dysregulation, lymphoproliferation and autoinflammatory disease.
On this page
Study tools
Target exams
Opening (must-hit)
"I hold this group of diseases on a three-mechanism framework. Immune dysregulation is failed tolerance (FOXP3, AIRE, CTLA4, LRBA); lymphoproliferation is failed apoptosis (the FAS pathway, in ALPS); autoinflammation is innate cytokine over-activation (NLRP3, MEFV, TNFRSF1A, MVK). The intersection is the cytokine storm, HLH or MAS. My first move in every case is to clear the HLH/MAS threat gate — fever plus splenomegaly plus cytopenias plus a very high ferritin — before anything else. Then I phenotype by the dominant mechanism, match therapy to the pathway, and reserve haematopoietic stem cell transplant for the severe immune-dysregulation and primary-HLH diseases." [1] [8]
References8ShowHide
- [1]Picard C Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. Journal of Clinical Immunology, 2015.PMID 26482257
- [3]Kuehn HS Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science, 2014.PMID 25213377
- [6]Rieux-Laucat F Scaling the tips of the ALPS. Biomedical Journal, 2021.PMID 34438083
- [7]George LA Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children. Paediatric Drugs, 2016.PMID 27139496
- [8]Henter JI HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood and Cancer, 2007.PMID 16937360
- [9]Jordan MB How I treat hemophagocytic lymphohistiocytosis. Blood, 2011.PMID 21828139
- [12]Romano M The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Annals of the Rheumatic Diseases, 2022.PMID 35623638
- [13]Stojanov S Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proceedings of the National Academy of Sciences, 2011.PMID 21478439